HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$1.25
Day range
$1.24 - $1.36
Year range
$1.05 - $10.16
Market cap
41.39M USD
Avg Volume
1.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.66M | 22.61% |
Net income | -19.68M | -19.37% |
Net profit margin | — | — |
Earnings per share | -0.51 | 30.14% |
EBITDA | -21.35M | -22.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.64M | 36.06% |
Total assets | 176.35M | 46.32% |
Total liabilities | 15.96M | 27.24% |
Total equity | 160.39M | — |
Shares outstanding | 31.36M | — |
Price to book | 0.24 | — |
Return on assets | -29.04% | — |
Return on capital | -31.45% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -19.68M | -19.37% |
Cash from operations | -19.54M | -14.35% |
Cash from investing | 19.21M | 228.44% |
Cash from financing | -343.00K | -99.42% |
Net change in cash | -664.00K | 94.18% |
Free cash flow | -12.75M | -1.57% |
About
Founded
2018
Headquarters
Website
Employees
77
